TY - JOUR
T1 - Management of severe peri-operative bleeding
T2 - Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022
AU - Kietaibl, Sibylle
AU - Ahmed, Aamer
AU - Afshari, Arash
AU - Albaladejo, Pierre
AU - Aldecoa, Cesar
AU - Barauskas, Giedrius
AU - De Robertis, Edoardo
AU - Faraoni, David
AU - Filipescu, Daniela C.
AU - Fries, Dietmar
AU - Godier, Anne
AU - Haas, Thorsten
AU - Jacob, Matthias
AU - Lancé, Marcus D.
AU - Llau, Juan V.
AU - Meier, Jens
AU - Molnar, Zsolt
AU - Mora, Lidia
AU - Rahe-Meyer, Niels
AU - Samama, Charles M.
AU - Scarlatescu, Ecaterina
AU - Schlimp, Christoph
AU - Wikkelsø, Anne J.
AU - Zacharowski, Kai
N1 - Funding Information:
Financial support and sponsorship: the systematic search was funded by the European Society of Anaesthesiology.
Funding Information:
Conflicts of interest: AAh received advisory fees from Stago, Haemonetics, CSL Behring, consulting fees from Nordic Pharma and is stock shareholder at Hemeo. PA received consultation fees from Pfizer BMS, Sanofi, Alexion. CA received consulting fees from Becton Dickinson. EDR received consultation fees from Baxter, Fresenius Kabi, MSD. He was President of the ESAIC during the period over which this guideline update was prepared. DCF received consulting fees and grants from Werfen. DFr received honoraria for lecturing, consulting fees and grants from AstraZeneca, Baxter, B. Braun, CSL Behring, LFB, Mitsubishi Tanabe Pharma, Octapharma. AG received honoraria and travel fees from Bayer-Healthcare, Boehringer-Ingelheim, Bristol-Myers-Squibb/Pfizer, Sanofi, LFB, CSL-Behring, Octapharma, Alexion. TH received honoraria for lecturing and consultation fees from Octapharma. SK received consultation fees from Baxter, Norgine, Werfen, Roche. JVL received honoraria for lecturing, educational programs or consultancies from Octapharma, CSL-Behring, Rovi, Sanofi, Cardinal. ZM received consultation fees from Pulsion Medical, ThermoFisher Scientific, CytoSorbents Europe and is senior medical director at CytoSorbents Europe. NRM received unrestricted grants for clinical studies from Biotest. ES received honoraria for lecturing from EurAsia Heart Foundation and CSL Behring. CS received research grants from CSL Behring, TEM International. Receipt of honoraria or consultation fees from CSL Behring, Boehringer Ingelheim, Portola, Shionogi, Octapharma. KZ received educational grants for his Department, honoraria for lectures from Haemonetics, med update, Pharmacosmos, Hexal AG, Vifor Pharma and advisory fees from Boston Scientific Medizintechnik GmbH, Wolters Kluwer, GE Healthcare. KZ received research grants from EU Horizon Europe CoVend and EU H2030 Envision. KZ was President of the ESAIC during the period over which this guideline update was prepared. AAf, GB, DFa, MJ, MDL, JM, LM, CMS and AW have not declared any conflict of interest.
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - BACKGROUNDManagement of peri-operative bleeding is complex and involves multiple assessment tools and strategies to ensure optimal patient care with the goal of reducing morbidity and mortality. These updated guidelines from the European Society of Anaesthesiology and Intensive Care (ESAIC) aim to provide an evidence-based set of recommendations for healthcare professionals to help ensure improved clinical management.DESIGNA systematic literature search from 2015 to 2021 of several electronic databases was performed without language restrictions. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used to assess the methodological quality of the included studies and to formulate recommendations. A Delphi methodology was used to prepare a clinical practice guideline.RESULTSThese searches identified 137999 articles. All articles were assessed, and the existing 2017 guidelines were revised to incorporate new evidence. Sixteen recommendations derived from the systematic literature search, and four clinical guidances retained from previous ESAIC guidelines were formulated. Using the Delphi process on 253 sentences of guidance, strong consensus (>90% agreement) was achieved in 97% and consensus (75 to 90% agreement) in 3%.DISCUSSIONPeri-operative bleeding management encompasses the patient's journey from the pre-operative state through the postoperative period. Along this journey, many features of the patient's pre-operative coagulation status, underlying comorbidities, general health and the procedures that they are undergoing need to be taken into account. Due to the many important aspects in peri-operative nontrauma bleeding management, guidance as to how best approach and treat each individual patient are key. Understanding which therapeutic approaches are most valuable at each timepoint can only enhance patient care, ensuring the best outcomes by reducing blood loss and, therefore, overall morbidity and mortality.CONCLUSIONAll healthcare professionals involved in the management of patients at risk for surgical bleeding should be aware of the current therapeutic options and approaches that are available to them. These guidelines aim to provide specific guidance for bleeding management in a variety of clinical situations.
AB - BACKGROUNDManagement of peri-operative bleeding is complex and involves multiple assessment tools and strategies to ensure optimal patient care with the goal of reducing morbidity and mortality. These updated guidelines from the European Society of Anaesthesiology and Intensive Care (ESAIC) aim to provide an evidence-based set of recommendations for healthcare professionals to help ensure improved clinical management.DESIGNA systematic literature search from 2015 to 2021 of several electronic databases was performed without language restrictions. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used to assess the methodological quality of the included studies and to formulate recommendations. A Delphi methodology was used to prepare a clinical practice guideline.RESULTSThese searches identified 137999 articles. All articles were assessed, and the existing 2017 guidelines were revised to incorporate new evidence. Sixteen recommendations derived from the systematic literature search, and four clinical guidances retained from previous ESAIC guidelines were formulated. Using the Delphi process on 253 sentences of guidance, strong consensus (>90% agreement) was achieved in 97% and consensus (75 to 90% agreement) in 3%.DISCUSSIONPeri-operative bleeding management encompasses the patient's journey from the pre-operative state through the postoperative period. Along this journey, many features of the patient's pre-operative coagulation status, underlying comorbidities, general health and the procedures that they are undergoing need to be taken into account. Due to the many important aspects in peri-operative nontrauma bleeding management, guidance as to how best approach and treat each individual patient are key. Understanding which therapeutic approaches are most valuable at each timepoint can only enhance patient care, ensuring the best outcomes by reducing blood loss and, therefore, overall morbidity and mortality.CONCLUSIONAll healthcare professionals involved in the management of patients at risk for surgical bleeding should be aware of the current therapeutic options and approaches that are available to them. These guidelines aim to provide specific guidance for bleeding management in a variety of clinical situations.
UR - http://www.scopus.com/inward/record.url?scp=85149296548&partnerID=8YFLogxK
U2 - 10.1097/EJA.0000000000001803
DO - 10.1097/EJA.0000000000001803
M3 - Review article
AN - SCOPUS:85149296548
SN - 0265-0215
VL - 40
SP - 226
EP - 304
JO - European Journal of Anaesthesiology
JF - European Journal of Anaesthesiology
IS - 4
ER -